VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

Author:  ["Steven A. Stacker","Carol Caesar","Megan E. Baldwin","Gillian E. Thornton","Richard A. Williams","Remko Prevo","David G. Jackson","Shin-ichi Nishikawa","Hajime Kubo","Marc G. Achen"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Metastasis to local lymph nodes via the lymphatic vessels is a common step in the spread of solid tumors. To investigate the molecular mechanisms underlying the spread of cancer by the lymphatics, we examined the ability of vascular endothelial growth factor (VEGF)-D, a ligand for the lymphatic growth factor receptor VEGFR-3/Flt-4, to induce formation of lymphatics in a mouse tumor model. Staining with markers specific for lymphatic endothelium demonstrated that VEGF-D induced the formation of lymphatics within tumors. Moreover, expression of VEGF-D in tumor cells led to spread of the tumor to lymph nodes, whereas expression of VEGF, an angiogenic growth factor which activates VEGFR-2 but not VEGFR-3, did not. VEGF-D also promoted tumor angiogenesis and growth. Lymphatic spread induced by VEGF-D could be blocked with an antibody specific for VEGF-D. This study demonstrates that lymphatics can be established in solid tumors and implicates VEGF family members in determining the route of metastatic spread.

Cite this article

Stacker, S., Caesar, C., Baldwin, M. et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7, 186–191 (2001). https://doi.org/10.1038/84635

View full text

>> Full Text:   VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with

Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Pla